Straw man argument. I challenge you to find anywhere I said hypogonadism should not be treated.
Given the lack of objective data — and the fact that your study pertains to a single institution — I'm free to insinuate that disruption of other hormones figures in the lack of satisfaction with TRT. The disruption itself is unequivocal. The only question is about the extent of the damage over time. I can further argue that hypogonadism is unpleasant enough that any TRT induces satisfaction by comparison, even if there are significant shortcomings. This was the case for me.
In any case, you distract from my main point, which is that hypogonadal men should be started on less disruptive treatments, and only if those fail should they proceed to conventional TRT.
